L&C BIO Co.,LTD (KOSDAQ:290650)
54,300
-6,900 (-11.27%)
Sep 19, 2025, 3:30 PM KST
L&C BIO Co.,LTD Revenue
L&C BIO Co.,LTD had revenue of 20.58B KRW in the quarter ending June 30, 2025, with 15.38% growth. This brings the company's revenue in the last twelve months to 75.98B, up 10.10% year-over-year. In the year 2024, L&C BIO Co.,LTD had annual revenue of 72.09B with 9.35% growth.
Revenue (ttm)
75.98B
Revenue Growth
+10.10%
P/S Ratio
17.59
Revenue / Employee
535.05M
Employees
142
Market Cap
1,336.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 72.09B | 6.17B | 9.35% |
Dec 31, 2023 | 65.93B | 13.35B | 25.40% |
Dec 31, 2022 | 52.57B | 6.90B | 15.10% |
Dec 31, 2021 | 45.68B | 12.70B | 38.53% |
Dec 31, 2020 | 32.97B | 3.82B | 13.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |